DCAF6 and myasthenia gravis: The epitope mapping of anti‐NRIP autoantibodies from six anti‐NRIP seropositive controls showed that most anti‐NRIP autoantibodies targeted the C‐terminal of NRIP but without WD6 and WD7 domains (FigureS5), similar to that in patients with MG.